MA24303A1 - Lignes cellulaires immortalisees pour la croissance du virus. - Google Patents

Lignes cellulaires immortalisees pour la croissance du virus.

Info

Publication number
MA24303A1
MA24303A1 MA24765A MA24765A MA24303A1 MA 24303 A1 MA24303 A1 MA 24303A1 MA 24765 A MA24765 A MA 24765A MA 24765 A MA24765 A MA 24765A MA 24303 A1 MA24303 A1 MA 24303A1
Authority
MA
Morocco
Prior art keywords
cell lines
immortalized cell
virus growth
virus
growth
Prior art date
Application number
MA24765A
Other languages
English (en)
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of MA24303A1 publication Critical patent/MA24303A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • C12N15/867Retroviral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/04Immortalised cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16651Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12051Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MA24765A 1996-08-13 1997-08-12 Lignes cellulaires immortalisees pour la croissance du virus. MA24303A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/696,200 US5672485A (en) 1996-08-13 1996-08-13 Immortalized cell lines for virus growth

Publications (1)

Publication Number Publication Date
MA24303A1 true MA24303A1 (fr) 1998-04-01

Family

ID=24796108

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24765A MA24303A1 (fr) 1996-08-13 1997-08-12 Lignes cellulaires immortalisees pour la croissance du virus.

Country Status (29)

Country Link
US (4) US5672485A (fr)
EP (1) EP0920491B1 (fr)
JP (3) JP3754088B2 (fr)
KR (1) KR100375871B1 (fr)
CN (1) CN1228119B (fr)
AR (1) AR008294A1 (fr)
AT (1) ATE362524T1 (fr)
AU (1) AU726820B2 (fr)
BR (1) BR9711067A (fr)
CA (1) CA2263725C (fr)
CO (1) CO4700552A1 (fr)
DE (1) DE69737735T2 (fr)
DK (1) DK0920491T3 (fr)
DZ (1) DZ2291A1 (fr)
ES (1) ES2285738T3 (fr)
GT (1) GT199700091A (fr)
HK (1) HK1022496A1 (fr)
HN (1) HN1997000124A (fr)
HU (1) HU226658B1 (fr)
IL (4) IL128511A (fr)
MA (1) MA24303A1 (fr)
MY (1) MY125594A (fr)
NZ (1) NZ334147A (fr)
PE (1) PE108198A1 (fr)
PT (1) PT920491E (fr)
SV (1) SV1997000071A (fr)
UY (1) UY24668A1 (fr)
WO (1) WO1998006824A1 (fr)
ZA (1) ZA977216B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
US6150505A (en) * 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6821741B1 (en) 2001-04-27 2004-11-23 University Hospitals Of Cleveland Cells for detection of enteroviruses
US6552172B2 (en) * 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
US20090217404A1 (en) * 2002-09-27 2009-08-27 Lowe Scott W Cell-based RNA interference and related methods and compositions
US7410557B2 (en) * 2002-09-30 2008-08-12 Honda Motor Co., Ltd. Hydrogen activating apparatus
WO2004056977A1 (fr) * 2002-12-13 2004-07-08 Aventis Pasteur, Inc. Production d'alvac sur des cellules souches aviaires
US20090186839A1 (en) * 2003-02-17 2009-07-23 Cold Spring Harbor Laboratory Model for studying the role of genes in chemoresistance
WO2004074445A2 (fr) * 2003-02-17 2004-09-02 Cold Spring Harbor Laboratory Modele d'etude du role de genes dans la resistance de tumeur a la chimiotherapie
US20050198700A1 (en) * 2003-03-07 2005-09-08 Avigenics, Inc. Genomic modification
US20040255345A1 (en) * 2003-03-07 2004-12-16 Rapp Jeffrey C. Production of transgenic avians
US20050034186A1 (en) * 2003-03-07 2005-02-10 Harvey Alex J. Site specific nucleic acid integration
EP1608219A4 (fr) * 2003-03-07 2007-03-14 Avigenics Inc Transgenese aviaire mediee par integrase
US20050273873A1 (en) * 2003-03-07 2005-12-08 Avigenics, Inc. Genomic modification
US7432101B2 (en) 2003-07-22 2008-10-07 Vivalis Production of poxviruses with adherent or non adherent avian cell lines
US20070275010A1 (en) * 2003-09-18 2007-11-29 Mark Feinberg Mva Vaccines
EP1528101A1 (fr) 2003-11-03 2005-05-04 ProBioGen AG Lignées cellulaires aviaires immortalisées pour la production de virus
US20060123504A1 (en) * 2004-12-07 2006-06-08 Avigenics, Inc. Methods of producing polyclonal antibodies
US20060174364A1 (en) * 2004-03-01 2006-08-03 Avigenics, Inc. Artificial chromosomes and transchromosomic avians
WO2006042214A1 (fr) * 2004-10-08 2006-04-20 Avigenics, Inc. Integrase modifiee et procedes d'utilisation
US8137907B2 (en) * 2005-01-03 2012-03-20 Cold Spring Harbor Laboratory Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
US20070044164A1 (en) * 2005-05-31 2007-02-22 Cold Spring Harbor Laboratory Methods for producing microRNAs
TR201909425T4 (tr) * 2005-10-05 2019-07-22 Alexion Pharma Inc Yüksek ti̇treli̇ vi̇rüsün hizli üreti̇mi̇
CA2656259C (fr) 2006-06-20 2013-03-19 Transgene S.A. Procede de production de poxvirus et compositions de poxvirus
CN100443588C (zh) * 2006-12-11 2008-12-17 中国农业科学院北京畜牧兽医研究所 静宁鸡胚成纤维细胞系及其培养方法
US8213704B2 (en) * 2007-05-09 2012-07-03 Kla-Tencor Corp. Methods and systems for detecting defects in a reticle design pattern
EP2014279A1 (fr) * 2007-06-22 2009-01-14 Pevion Biotech AG Virosomes contenant de l'hémagglutinine dérivée du virus de la grippe produit par les lignées cellulaires; les compositions, les méthodes de production, l'emploi des virosomes
JP5421250B2 (ja) 2007-07-03 2014-02-19 トランスジーン ソシエテ アノニム トリ不死化細胞株
US8357531B2 (en) * 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
WO2009055724A2 (fr) * 2007-10-26 2009-04-30 Cold Spring Harbor Laboratory Procédés haut rendement pour la détermination fonctionnelle de l'efficacité de l'interférence d'arn
CA2715719C (fr) * 2008-02-25 2019-08-06 Baxter International Inc. Procede de production de lignees cellulaires continues
JP2012526532A (ja) 2009-05-12 2012-11-01 トランジェーヌ、ソシエテ、アノニム 不死化鳥類細胞系およびその用途
WO2010144797A2 (fr) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Vaccins contre la grippe avec immunogénicité accrue et leurs utilisations
DK2596099T3 (da) 2010-07-20 2020-02-24 Bavarian Nordic As Fremgangsmåde til høst af ekspressionsprodukter
FR3008992A1 (fr) 2013-07-25 2015-01-30 Agronomique Inst Nat Rech Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
EP3226894B1 (fr) 2014-12-01 2019-08-07 Transgene SA Formulation stable et liquide de virus de la vaccine
PL3227433T3 (pl) * 2014-12-04 2019-01-31 Intervet International B.V. Unieśmiertelnione fibroblasty zarodków kurzych
KR101768581B1 (ko) * 2015-08-13 2017-08-17 전북대학교 산학협력단 자발적 불멸화된 체세포의 단일 세포로부터 리프로그래밍 세포주의 제조방법
US20190144831A1 (en) * 2015-12-11 2019-05-16 Intervet Inc. Immortalised chicken embryonic epithelial kidney cells
WO2017191147A1 (fr) 2016-05-04 2017-11-09 Transgene Sa Polythérapie avec un ligand de tlr9 cpg
EP3522920A2 (fr) 2016-10-10 2019-08-14 Transgene SA Polythérapie à base d'un produit immunothérapeutique et de modulateurs de mdsc
US20200179507A1 (en) 2016-11-17 2020-06-11 Regents Of The University Of Minnesota Immortalized cell lines and methods of use
AU2018269319A1 (en) 2017-05-15 2019-11-07 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
CA3062549A1 (fr) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Composition contenant un virus stable
AU2018287159A1 (en) 2017-06-21 2020-01-16 Transgene Personalized vaccine
CN107858323B (zh) * 2017-11-08 2020-10-09 广东省生物资源应用研究所 一种红耳龟胚胎成纤维细胞系及其构建方法
CN109234239B (zh) * 2018-07-13 2021-09-14 广东永顺生物制药股份有限公司 一种鸭瘟病毒的培养方法
US20210187100A1 (en) 2018-09-06 2021-06-24 Bavarian Nordic A/S Storage Improved Poxvirus Compositions
US20230031097A1 (en) 2019-12-20 2023-02-02 Intervet Inc. Multivalent hvt vector vaccine
CN115243717A (zh) 2020-03-12 2022-10-25 巴法里安诺迪克有限公司 改善痘病毒稳定性的组合物
AU2021309007A1 (en) 2020-07-13 2023-02-16 Transgene Treatment of immune depression
CA3190070A1 (fr) 2020-09-07 2022-03-10 Martijn Alexander LANGEREIS Vaccin a souche ha pour cibles positives aux anticorps ha
CN116648259A (zh) 2020-12-24 2023-08-25 英特维特国际股份有限公司 多价hvt载体疫苗
EP4370150A1 (fr) 2021-07-13 2024-05-22 Intervet International B.V. Surmonter l'interférence d'anticorps chez les oiseaux
WO2023213763A1 (fr) 2022-05-02 2023-11-09 Transgene Poxvirus codant pour un agent de liaison comprenant un sdab anti-pd-l1
WO2023213764A1 (fr) 2022-05-02 2023-11-09 Transgene Polypeptide de fusion comprenant un anti-pd-l1 sdab et un membre du tnfsf
WO2023213946A1 (fr) 2022-05-05 2023-11-09 Intervet International B.V. Nouveau vaccin à vecteur hvt multivalent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3058438B2 (ja) * 1990-10-19 2000-07-04 財団法人化学及血清療法研究所 ヒト肝臓組織特異的ウイルスの感染可能な霊長類の不死化肝細胞およびその調製方法
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth

Also Published As

Publication number Publication date
JP2005118053A (ja) 2005-05-12
JP3754088B2 (ja) 2006-03-08
WO1998006824A1 (fr) 1998-02-19
US5985642A (en) 1999-11-16
US5672485A (en) 1997-09-30
CA2263725C (fr) 2002-10-15
ZA977216B (en) 1998-02-19
CA2263725A1 (fr) 1998-02-19
MY125594A (en) 2006-08-30
IL158301A0 (en) 2004-05-12
DE69737735T2 (de) 2008-01-31
KR20000029968A (ko) 2000-05-25
HUP0000188A3 (en) 2005-11-28
JP2006320328A (ja) 2006-11-30
US6207415B1 (en) 2001-03-27
ES2285738T3 (es) 2007-11-16
IL128511A (en) 2004-06-01
NZ334147A (en) 2000-08-25
DK0920491T3 (da) 2007-09-17
AU726820B2 (en) 2000-11-23
KR100375871B1 (ko) 2003-03-10
PE108198A1 (es) 1999-01-21
PT920491E (pt) 2007-07-27
IL158302A0 (en) 2004-05-12
SV1997000071A (es) 2000-07-06
IL128511A0 (en) 2000-01-31
HK1022496A1 (en) 2000-08-11
EP0920491A1 (fr) 1999-06-09
US5879924A (en) 1999-03-09
GT199700091A (es) 1997-08-12
HUP0000188A2 (hu) 2000-06-28
UY24668A1 (es) 1998-02-02
CN1228119B (zh) 2012-04-04
EP0920491B1 (fr) 2007-05-16
DE69737735D1 (de) 2007-06-28
BR9711067A (pt) 1999-08-17
ATE362524T1 (de) 2007-06-15
AR008294A1 (es) 1999-12-29
IL158303A0 (en) 2004-05-12
HN1997000124A (es) 1999-03-19
HU226658B1 (en) 2009-06-29
AU4069197A (en) 1998-03-06
DZ2291A1 (fr) 2002-12-25
JP2000516095A (ja) 2000-12-05
CO4700552A1 (es) 1998-12-29
CN1228119A (zh) 1999-09-08

Similar Documents

Publication Publication Date Title
MA24303A1 (fr) Lignes cellulaires immortalisees pour la croissance du virus.
DE69712848D1 (de) Kulturgefäss
TR199600001A2 (tr) Estrojen agonistleri / antagonistleri.
DE69831948D1 (de) Selbständiges zellwachstumssystem
NL1007544A1 (nl) Membraan.
DE60032177D1 (de) Navigationssystem mit eindeutigen, Manöver ankündigenden Audiotönen
IT1304321B1 (it) Mezzi contenitori
EE9800240A (et) Meetod fermenteeritava virde valmistamiseks
FR2821712B1 (fr) Godet pour culture de vegetaux
FR2724180B1 (fr) Bioreacteur, en particulier pour micro-gravite
FR2720808B1 (fr) Système pour équilibrer des couples changeants.
IT1304906B1 (it) Mezzi contenitori
NO990764D0 (no) Bioreaktor
ES1035493Y (es) Contenedor desmontable.
FR2721234B1 (fr) Broyeurs pour grandes cultures.
NO962290L (no) Uthaler for fiskeliner
FR2786060B1 (fr) Support de culture pour sacs
FR2775432B1 (fr) Embouts pour vacuotherapie
DK199801007A (da) Flamolina velutipes dyrknings container
SE9500662D0 (sv) Låda, speciellt brevlåda
NO980228D0 (no) Beholdersystem
FR2756745B1 (fr) Coinceur, notamment pour alpiniste
ES1035420Y (es) Contenedor.
IT234565Y1 (it) Supporto basculante per contenitori.
ES1035000Y (es) Agrupador-sustentador de envases.